 | United States - 1977 - 1276 halaman
...defined in subsection (e) of this section, printed prominently and in type at least half as large as ood, Drug, and Cosmetic Act [21 USC 301 et seq.] or...seq.], or the laws of the jurisdiction in which th subsection (e) of this section, and (3) such other information in brief summary relating to side effects,... | |
 | United States - 1964 - 1098 halaman
...defined in subsection (e) of this section, printed prominently and in type at least half as large as that used for any trade or brand name thereof, (2)...such drug to the extent required for labels under subsection (e) of this section, and (3) such other information in brief summary relating to side effects,... | |
 | United States. Congress. Senate. Government Operations - 1962 - 1078 halaman
...such phrases as "Each tablet contains," etc. Section 502(n)(2) of the Act requires a true statement of "the formula showing quantitatively each ingredient...the extent required for labels under Section 502(e) , . . ." ÏUG COORDINATION 2939 We find nothing in this language of Sections 502(n) or 5O2(e) requiring... | |
 | United States. Congress. House. Committee on Government Operations - 1964 - 540 halaman
...provides that a prescription drug is misbranded unless any advertisement for the drug "Includes . . . information In brief summary relating to side effects, contraindications, and effectiveness" as required in regulations to be Issued by the Secretary. Any regulations extending to other material... | |
 | United States. Congress. Senate. Committee on Commerce - 1965 - 886 halaman
...ty|(e at least, half as large as that used for any trade or brand name thereof.' the ingredients and "such other information in brief summary relating...effectiveness as shall be required in regulations' (sec. r,02(n)). "<«) A drug which is not. safe for use other than on prescription must be lulK-led... | |
 | United States. Congress. Senate. Commerce - 1965 - 1168 halaman
...tyi>e at. least, half as large as that used for any trade or brand name thereof.' the ingredients and 'such other information in brief summary relating...effects, contraindications, and effectiveness as shall l>e required in regulations' (sec. 502(n)». "<() A .drug which is not, safe for use other than on... | |
 | United States. Congress. House Interstate and Foreign Commerce - 1966 - 574 halaman
...established name as defined in section 502 (e), printed prominently and in type at least half as large as that used for any trade or brand name thereof, (2)...drug to the extent required for labels under section 502 (e), :l FDC Regs., part 8. and (3) such other information in brief summary relating to side effects,... | |
 | United States - 1966 - 556 halaman
...ingredient of such drug to the extent required for labels under section 502 (e), » FDC Begs., part 8. and (3) such other information in brief summary relating...effectiveness as shall be required in regulations which shall be Issued by the Secretary in accordance with the procedure specified in section 701 (e) of this Act:... | |
 | United States. Congress. House. Interstate and Foreign Commerce - 1966 - 360 halaman
...type at least half as large as that used for any trade or brand name thereof," the ingredients and "such other information in brief summary relating...effectiveness as shall be required in regulations." (Sec. 502(n)) (m) A drug which is not safe for use other than on prescription must be labeled "Caution:... | |
| |
... a true statement of ( 1 ) the established name as defined in section 502 (e) , printed prominently and in type at least half as large as that used for any trade or brand name thereof... 
